Thursday 25th February 2021, 16:30-17:30
This webinar, presented by Professor Dean Fennell will provide an overview of recent advances in immunotherapy for mesothelioma, data from two phase III trials. Implications for therapy, further opportunities for improving survival outcomes will also be explored
Our webinars are for healthcare professionals only.
Watch On Demand
Speakers
Dean Fennell
Dean Fennell is Professor & consultant in Thoracic Medical Oncology, and Director of the Leicester Mesothelioma Programme based at the University of Leicester/University Hospitals of Leicester NHS Trust. He is an internationally recognised key opinion leader, clinical investigator and translational research in mesothelioma. He has led several investigator-initiated trials from phase 1 through phase III. He is member of the IASLC mesothelioma taskforce, steering committee for the British Lung Foundation mesothelioma research network, past president of the International mesothelioma interest group, co-author of the UK BTS, and European (ESMO, ERS) mesothelioma treatment guidelines and served two terms on the EORTC board. Prof. Fennell is currently the Leicester lead for the ground breaking Cancer Research UK TraceRx/Darwin/PEACE and BLF supported MEDUSA phylogenetic studies. Prof. Fennell held two prestigious CRUK clinician scientist and MRC doctoral fellowships. He originally trained in pharmacology (1st class) and medicine at UCL where he was awarded several prizes. He completed medical training in the London Golden circuit (Hammersmith, Brompton, Guy's, St Thomas's), and completed his specialist training at Barts Hospital. Prof. Fennell has published over 100 peer reviewed articles in journals including The Lancet, Lancet Oncology, New England Journal of Medicine, Nature, Nature Reviews Cancer, and Proceedings of the National Academy of Sciences.
Rachel Thomas
Rachel, LCNUK Committee member, qualified as a nurse in September 2000 and initially specialised in HIV nursing, undertaking an MSc in Health Care Research. Rachel has worked at Guy’s and St Thomas NHS Trust for 7 yrs and became a Mesothelioma/Lung Cancer Clinical Nurse Specialist 6yrs ago. Rachel really enjoys working in the field of lung cancer as it has many similarities to HIV in the early days. Since working in this role Rachel has become part of the Asbestos Sub-committee at Parliament and helped set up a nurse led clinic for patients on TKI’s. Rachel also runs a successful Mesothelioma support group and publishes a newsletter for all the Mesothelioma patients who attend Guy’s and St Thomas’ for treatment. As part of Rachel’s role she has also project managed education programmes for lung cancer health professionals across London on setting up a nurse led clinic and evidenced based prescribing of TKI’s.
Irwin Mitchell LLP has almost 40 years’ experience in successfully recovering compensation for our clients whose lives are affected by mesothelioma and other asbestos-related illnesses. Our specialist solicitors, (the majority of whom are APIL accredited) have helped and supported several thousand people to successfully claim compensation after exposure to asbestos through their work and / or domestic circumstances. We have been at the forefront of recovering compensation to fund the costs of non-NHS funded treatments (in appropriate cases), winning many Appeal Court cases over the decades, fighting for positive changes in case law. We support many charities including Mesothelioma UK, Roy Castle, The June Hancock Mesothelioma Research Fund and campaign alongside the Forum of Asbestos Victim Support Groups – UK.